Lumenis Files Registration Statement for Proposed Public Offering and NASDAQ Listing

YOKNEAM, ISRAEL–(Marketwired – Dec 9, 2013) – Lumenis Ltd., a leading global provider of minimally invasive clinical solutions for surgical, ophthalmic and aesthetic applications, today announced that that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed public offering of its ordinary shares. The number of shares to be offered and the price range for the offering have not yet been…